Go to Russian website Go to English website

Corporate Mission

CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients that will help prolong their lives. 

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics. Currently, the company is developing two R&D programs:

Plasmid-based stimulant of anti-cancer immune response, acting via activation of innate immunity

Tumor-selective oncolytic adenovirus